| AMNEAL PHARMACEUTICALS |
| USA |
| Gesundheit |
| US03168L1052 / A2JLMD |
| 2DT (Frankfurt) / AMRX (NASDAQ) |
| FRA:2DT, ETR:2DT, 2DT:GR, NASDAQ:AMRX |
| - |
| https://www.amneal.com/ |
|
Amneal Pharmaceuticals Inc. is a renowned entity i..
>Volltext.. |
| 3261.09 Mio. EUR |
| 5408.64 Mio. EUR |
| 2501.74 Mio. EUR |
| 515.52 Mio. EUR |
| 5.03 Mio. EUR |
| 0.02 EUR |
| 2289.3 Mio. EUR |
| 201.14 Mio. EUR |
| 279.32 Mio. EUR |
| 0.27 |
| 3.89% |
| - |
| - |
| - |
| - |
| AMNEAL |
| 18.12.25 |
|